Immunic Inc (NASDAQ: IMUX) is 10.00% higher on its value in year-to-date trading and has touched a low of $0.97 and a high of $2.11 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The IMUX stock was last observed hovering at around $1.02 in the last trading session, with the day’s gains setting it 0.08%.
Currently trading at $1.10, the stock is -0.68% and -5.74% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.17 million and changing 7.84% at the moment leaves the stock -15.82% off its SMA200. IMUX registered -23.08% loss for a year compared to 6-month gain of 1.85%. The firm has a 50-day simple moving average (SMA 50) of $1.167 and a 200-day simple moving average (SMA200) of $1.30673.
The stock witnessed a -13.39% loss in the last 1 month and extending the period to 3 months gives it a -30.82%, and is 4.76% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 5.68% over the week and 6.23% over the month.
Immunic Inc (IMUX) has around 77 employees, a market worth around $106.86M and $0.00M in sales. Distance from 52-week low is 13.40% and -47.87% from its 52-week high. The company has generated returns on investments over the last 12 months (-234.04%).
The EPS is expected to grow by 54.30% this year, but quarterly earnings will post 0.00% year-over-year. Quarterly sales are estimated to shrink 0.00% in year-over-year returns.
Immunic Inc (IMUX) Top Institutional Holders
73.0 institutions hold shares in Immunic Inc (IMUX), with institutional investors hold 65.53% of the company’s shares. The shares outstanding are 90.08M, and float is at 87.36M with Short Float at 5.62%. Institutions hold 64.85% of the Float.
The top institutional shareholder in the company is BVF INC/IL with over 8.9 million shares valued at $9.88 million. The investor’s holdings represent 9.15% of the IMUX Shares outstanding. As of 2024-06-30, the second largest holder is AVIDITY PARTNERS MANAGEMENT LP with 8.9 million shares valued at $9.88 million to account for 9.15 of the shares outstanding. The other top investors are SOLEUS CAPITAL MANAGEMENT, L.P. which holds 7.29 million shares representing 7.4954% and valued at over $8.1 million, while JANUS HENDERSON GROUP PLC holds 7.2701 of the shares totaling 7.07 million with a market value of $7.96 million.
Immunic Inc (IMUX) Insider Activity
The most recent transaction is an insider purchase by Rudick Richard Alan, the company’s Director. SEC filings show that Rudick Richard Alan bought 87,300 shares of the company’s common stock on Nov 12 ’24 at a price of $1.15 per share for a total of $0.1 million. Following the purchase, the insider now owns 87300.0 shares.
